FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils

被引:86
作者
Treffers, Louise W. [1 ,2 ]
van Houdt, Michel [1 ,2 ]
Bruggeman, Christine W. [1 ,2 ]
Heineke, Marieke H. [3 ]
Zhao, Xi Wen [1 ,2 ]
van der Heijden, Joris, I [1 ,2 ]
Nagelkerke, Sietse Q. [1 ,2 ,4 ]
Verkuijlen, Paul J. J. H. [1 ,2 ]
Geissler, Judy [1 ,2 ]
Lissenberg-Thunnissen, Suzanne [1 ,2 ]
Valerius, Thomas [5 ]
Peipp, Matthias [5 ]
Franke, Katka [1 ,2 ]
van Bruggen, Robin [1 ,2 ]
Kuijpers, Taco W. [1 ,2 ,4 ]
van Egmond, Marjolein [3 ]
Vidarsson, Gestur [1 ,2 ]
Matlung, Hanke L. [1 ,2 ]
van den Berg, Limo K. [1 ,2 ,3 ]
机构
[1] Univ Amsterdam, Amsterdam UMC, Sanquin Res, Amsterdam, Netherlands
[2] Univ Amsterdam, Amsterdam UMC, Landsteiner Lab, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Amsterdam Infect & Immun Inst, Amsterdam UMC, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands
[4] Univ Amsterdam, Amsterdam UMC, Ernma Childrens Hosp, Amsterdam, Netherlands
[5] Univ Kiel, Dept Internal Med 2, Div Stem Cell Transplantat & Immunotherapy, Kiel, Germany
关键词
Fc gamma RIIIb; neutrophil; ADCC; cancer; granulocyte; Fc-receptor; CNV; glycoengineering; COPY NUMBER VARIATION; LOW-FUCOSE IGG1; CELLULAR CYTOTOXICITY; PROMOTE PHAGOCYTOSIS; CD20; ANTIBODY; RECEPTOR-III; AFFINITY; BINDING; CD16B; FUCOSYLATION;
D O I
10.3389/fimmu.2018.03124
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The function of the low-affinity IgG-receptor Fc gamma RIIIb (CD16b), which is uniquely and abundantly expressed on human granulocytes, is not clear. Unlike the other Fc gamma receptors (Fc gamma R), it is a glycophosphatidyl inositol (GPI) -anchored molecule and does not have intracellular signaling motifs. Nevertheless, Fc gamma RIIIb can cooperate with other Fc gamma R to promote phagocytosis of antibody-opsonized microbes by human neutrophils. Here we have investigated the role of Fc gamma RIIIb during antibody-dependent cellular cytotoxicity (ADCC) by neutrophils toward solid cancer cells coated with either trastuzumab (anti-HER2) or cetuximab (anti-EGFR). Inhibiting Fc gamma RIIIb using CD16-F(ab')(2) blocking antibodies resulted in substantially enhanced ADCC. ADCC was completely dependent on Fc gamma RIIa (CD32a) and the enhanced ADCC seen after Fc gamma RIIIb blockade therefore suggested that Fc gamma RIIIb was competing with Fc gamma RIIa for IgG on the opsonized target cells. Interestingly, the function of neutrophil Fc gamma RIIIb as a decoy receptor was further supported by using neutrophils from individuals with different gene copy numbers of FCGR3B causing different levels of surface Fc gamma RIIIb expression. Individuals with one copy of FCGR3B showed higher levels of ADCC compared to those with two or more copies. Finally, we show that therapeutic antibodies intended to improve Fc gamma RIIIa (CD16a)-dependent natural killer (NK) cell ADCC due to the lack of fucosylation on the N-linked glycan at position N297 of the IgG(1) heavy chain Fc-region, show decreased ADCC as compared to regularly fucosylated antibodies. Together, these data confirm Fc gamma RIIIb as a negative regulator of neutrophil ADCC toward tumor cells and a potential target for enhancing tumor cell destruction by neutrophils.
引用
收藏
页数:13
相关论文
共 72 条
[21]   Neutrophil infiltration into human gliomas [J].
Fossati, G ;
Ricevuti, G ;
Edwards, SW ;
Walker, C ;
Dalton, A ;
Rossi, ML .
ACTA NEUROPATHOLOGICA, 1999, 98 (04) :349-354
[22]   Differential role of neutrophil Fcγ receptor IIIb (CD16) in phagocytosis, bacterial killing, and responses to immune complexes [J].
Fossati, G ;
Moots, RJ ;
Bucknall, RC ;
Edwards, SW .
ARTHRITIS AND RHEUMATISM, 2002, 46 (05) :1351-1361
[23]   Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab [J].
Golay, Josee ;
Da Roit, Fabio ;
Bologna, Luca ;
Ferrara, Claudia ;
Leusen, Jeanette H. ;
Rambaldi, Alessandro ;
Klein, Christian ;
Introna, Martino .
BLOOD, 2013, 122 (20) :3482-3491
[24]  
Graf S. W., ARTHRITIS RES THER, V14, pR28
[25]   Adverse Events of Monoclonal Antibodies Used for Cancer Therapy [J].
Guan, Mei ;
Zhou, Yan-Ping ;
Sun, Jin-Lu ;
Chen, Shu-Chang .
BIOMED RESEARCH INTERNATIONAL, 2015, 2015
[26]  
HEIFETS L, 1982, J RETICULOENDOTH SOC, V31, P381
[27]  
Hernandez-Ilizaliturri FJ, 2003, CLIN CANCER RES, V9, P5866
[28]   THE PI-LINKED RECEPTOR FCRIII IS RELEASED ON STIMULATION OF NEUTROPHILS [J].
HUIZINGA, TWJ ;
VANDERSCHOOT, CE ;
JOST, C ;
KLAASSEN, R ;
KLEIJER, M ;
VONDEMBORNE, AEGK ;
ROOS, D ;
TETTEROO, PAT .
NATURE, 1988, 333 (6174) :667-669
[29]   CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis [J].
Jaiswal, Siddhartha ;
Jamieson, Catriona H. M. ;
Pang, Wendy W. ;
Park, Christopher Y. ;
Chao, Mark P. ;
Majeti, Ravindra ;
Traver, David ;
van Rooijen, Nico ;
Weissman, Irving L. .
CELL, 2009, 138 (02) :271-285
[30]   Prophylactic anti-D preparations display variable decreases in Fc-fucosylation of anti-D [J].
Kapur, Rick ;
Della Valle, Luciana ;
Verhagen, Onno J. H. M. ;
Ederveen, Agnes Hipgrave ;
Ligthart, Peter ;
de Haas, Masja ;
Kumpel, Belinda ;
Wuhrer, Manfred ;
van der Schoot, C. Ellen ;
Vidarsson, Gestur .
TRANSFUSION, 2015, 55 (03) :553-562